InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Daly James M, Director. Insider active across 6 companies, notably Halozyme Therapeutics, INC.. Cumulatively, 22 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €979k. Activity tracked since 5 May 2021. The latest transaction was filed on 15 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Daly James M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
151 股@ US$82.620.0001% mcap50.4% 占其流量Common StockSEC:0001061983-26-000078:0
454 股Common StockSEC:0001628280-26-044307:0
8,107 股Common StockSEC:0001560782-26-000002:0
2,851 股0Common StockSEC:0001061983-26-000061:0
191 股@ US$65.370.0001% mcap100.0% 占其流量Common StockSEC:0001061983-26-000037:0
197 股@ US$63.44100.0% 占其流量Common StockSEC:0001061983-26-000010:0
30,000 股@ US$22.3661100.0% 占其流量Common StockSEC:0001560782-25-000006:0
715 股0Common StockSEC:0001628280-25-032850:0
9,387 股Common StockSEC:0001415889-25-015271:0
9,470 股@ US$65.0623.9% 占其流量Common StockSEC:0001628280-25-009079:0
714 股0Common StockSEC:0000950170-24-078750:0
6,652 股Common StockSEC:0001415889-24-015087:0
20,000 股@ US$100.4576.1% 占其流量Common StockSEC:0000899243-24-000243:0
10,000 股@ US$43.711100.0% 占其流量Common StockSEC:0001415889-23-012257:0
1,198 股0Common StockSEC:0000899243-23-016057:0
3,059 股Common StockSEC:0001209191-23-034695:0
8,065 股0Common StockSEC:0001415889-23-007689:0
60,414 股0Common StockSEC:0001628280-23-000422:0
35,082 股0Common StockSEC:0001628280-22-024219:0
6,206 股0Restricted Stock UnitSEC:0001179110-22-002908:0
13,568 股0Common StockSEC:0001628280-22-000412:0
5,230 股0Restricted Stock UnitSEC:0001179110-21-004971:0
22 条申报中的 22 条
About Daly James M
Daly James M is Director at Madrigal Pharmaceuticals, INC., Acadia Pharmaceuticals INC, Halozyme Therapeutics, INC., CYTOKINETICS INC, Bellicum Pharmaceuticals, INC and Cytokinetics INC. The 22 filings on record cover the period from 2021-05-06 to 2026-07-16, and in the sampled recent filings, sell amounts total EUR 979282, with notable other transactions at Madrigal Pharmaceuticals, INC. on 2024-04-03 and 2025-02-28, as well as sells at Acadia Pharmaceuticals INC on 2025-11-12 and at Halozyme Therapeutics, INC. on 2023-08-15.
